A 24-year-old woman from Mumbai attends the infertility clinic with a 2-year history of amenorrhoea. She reports menarche at age 13 with regular 28-day cycles until age 22, when cycles became irregular and then ceased. She denies weight loss, excessive exercise, or galactorrhoea. On examination, BMI is 31 kg/m², and she has mild facial hirsutism and acne. Temperature is 37°C, and vital signs are normal. Serum TSH is 2.1 mIU/L (normal), serum prolactin is 12 ng/mL (normal), and serum testosterone is 68 ng/dL (elevated; normal <50). Pelvic ultrasound shows bilateral enlarged ovaries with multiple small cysts and increased stromal echogenicity. What is the most appropriate first-line management?

Explanation

## First-Line Management of PCOS-Related Amenorrhoea and Infertility ### Clinical Context This patient has: - **Amenorrhoea** (2 years) secondary to anovulation - **Hyperandrogenism** (elevated testosterone 68 ng/dL) - **Polycystic ovaries** on ultrasound with stromal hypertrophy - **Obesity** (BMI 31 kg/m²) - **Normal TSH and prolactin** (exclude other causes) - **Diagnosis:** PCOS with secondary amenorrhoea and infertility ### Why Metformin + Lifestyle Modification Is First-Line **Key Point:** Insulin resistance is the **root pathophysiology** in 50–70% of PCOS cases, even in lean women. Addressing insulin resistance is the foundation of all PCOS management. #### Mechanism of Metformin in PCOS ```mermaid flowchart TD A[Metformin]:::action --> B[↓ Hepatic glucose production]:::outcome A --> C[↓ Insulin resistance]:::outcome C --> D[↓ Fasting insulin levels]:::outcome D --> E[↓ LH stimulation of theca cells]:::outcome E --> F[↓ Androgen synthesis]:::outcome F --> G[↑ SHBG synthesis in liver]:::outcome G --> H[↓ Free testosterone]:::outcome H --> I[Restoration of normal follicle development]:::outcome I --> J[Ovulation resumes]:::action C --> K[↓ Weight gain tendency]:::outcome K --> L[Weight loss/stabilization]:::action ``` **High-Yield:** Metformin improves ovulation rates in PCOS by **reducing insulin levels**, which decreases LH-driven androgen production and allows normal follicle maturation. #### Lifestyle Modification (Diet + Exercise) | Intervention | Mechanism | Outcome | |--------------|-----------|----------| | **5–10% weight loss** | Improves insulin sensitivity | Restores ovulation in 50–70% of obese PCOS women | | **Regular aerobic exercise** | Reduces visceral adiposity | Improves glucose tolerance and SHBG | | **Low glycaemic index diet** | Reduces postprandial hyperinsulinaemia | Decreases androgen production | | **Combined approach** | Synergistic metabolic improvement | Superior outcomes vs. medication alone | **Clinical Pearl:** A 5–10% weight loss in obese PCOS women can restore ovulation without any medication. This should always be the foundation. ### Evidence Base **High-Yield:** - **Metformin 1500 mg daily** is the **first-line pharmacological agent** for PCOS (ASRM, ESHRE, ACOG guidelines) - **Ovulation restoration rate:** 30–40% with metformin alone; 50–70% with metformin + lifestyle modification - **Metabolic benefits:** Improves insulin sensitivity, reduces weight gain, decreases cardiovascular risk - **Safe in infertility:** No teratogenic effects; can be continued during pregnancy ### Why Other Options Are NOT First-Line #### Leuprolide Acetate (GnRH Agonist) - **Role:** Suppresses LH and FSH, reducing androgen production - **Why not first-line:** - Does NOT address underlying insulin resistance - Causes hypoestrogenaemia (hot flushes, vaginal dryness, bone loss) - Expensive and requires monitoring - Reserved for severe hyperandrogenism or when metformin fails - **Not recommended as initial therapy** [cite:ASRM PCOS Guidelines] #### Spironolactone 100 mg Daily - **Role:** Aldosterone antagonist; blocks androgen receptors - **Why not first-line:** - Does NOT restore ovulation (anti-androgenic, not pro-ovulatory) - Used for **cosmetic symptoms** (hirsutism, acne), not infertility - **Teratogenic** (feminizes male fetuses) — contraindicated if pregnancy is planned - Should be combined with metformin, not used alone - **Second-line for hirsutism management only** #### Clomiphene Citrate 50 mg Daily - **Role:** Selective oestrogen receptor modulator; increases FSH to induce ovulation - **Why not first-line:** - **Appropriate SECOND-line agent** if metformin + lifestyle modification fails (after 3–6 months) - Does NOT address insulin resistance or hyperandrogenism - Risk of multiple pregnancies (5–10% twins) - Ovarian hyperstimulation syndrome (OHSS) risk - Should be used **after** metabolic optimization ### Recommended Management Sequence ```mermaid flowchart TD A[PCOS diagnosis confirmed]:::outcome --> B[Lifestyle modification + Metformin 1500 mg/day]:::action B --> C{Ovulation restored in 3-6 months?}:::decision C -->|Yes| D[Continue metformin + lifestyle]:::action C -->|No| E[Add Clomiphene citrate 50 mg/day]:::action D --> F[Achieve pregnancy]:::outcome E --> G{Ovulation achieved?}:::decision G -->|Yes| H[Proceed to timed intercourse/IUI]:::action G -->|No| I[Consider IVF]:::action H --> J[Achieve pregnancy]:::outcome ``` **Tip:** Always counsel on weight loss and diet FIRST. Metformin is the pharmacological anchor. Clomiphene is reserved for ovulation induction if metformin fails.